Neuroinflammatory processes in Parkinson's disease
- PMID: 12666098
- DOI: 10.1002/ana.10481
Neuroinflammatory processes in Parkinson's disease
Abstract
Parkinson's disease (PD) is a movement disorder characterized by the progressive degeneration of dopaminergic neurons in the midbrain. To date, its cause remains unknown and the mechanism of nerve cell death uncertain. Apart from the massive loss of dopaminergic neurons, PD brains also show a conspicuous glial reaction together with signs of a neuroinflammatory reaction manifested by elevated cytokine levels and upregulation of inflammatory-associated factors such as cyclooxygenase-2 and inducible nitric oxide synthase. Mounting evidence also suggests a possible deleterious effect of these neuroinflammatory processes in experimental models of the disease. We propose that, in PD, neuroinflammation plays a role in the cascade of events leading to nerve cell death, thus propagating the neurodegenerative process. In this review, we summarize and discuss the latest findings regarding neuroinflammatory aspects in PD.
Similar articles
-
Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease.J Neurosci Res. 2005 Sep 15;81(6):874-82. doi: 10.1002/jnr.20599. J Neurosci Res. 2005. PMID: 16041799
-
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.Mol Cell Neurosci. 2000 Dec;16(6):724-39. doi: 10.1006/mcne.2000.0914. Mol Cell Neurosci. 2000. PMID: 11124893
-
Neuroinflammatory processes in Parkinson's disease.Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S9-S15. doi: 10.1016/j.parkreldis.2004.10.013. Parkinsonism Relat Disord. 2005. PMID: 15885630 Review.
-
Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: dual roles of mitogen-activated protein kinase signaling pathways.Glia. 2005 Aug 1;51(2):98-110. doi: 10.1002/glia.20190. Glia. 2005. PMID: 15789435
-
Pathogenesis of nigral cell death in Parkinson's disease.Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S3-7. doi: 10.1016/j.parkreldis.2004.10.012. Parkinsonism Relat Disord. 2005. PMID: 15885625 Review.
Cited by
-
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.Mediators Inflamm. 2013;2013:952375. doi: 10.1155/2013/952375. Epub 2013 Jun 27. Mediators Inflamm. 2013. PMID: 23935251 Free PMC article. Review.
-
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2933-8. doi: 10.1073/pnas.0813361106. Epub 2009 Feb 5. Proc Natl Acad Sci U S A. 2009. PMID: 19196989 Free PMC article.
-
Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.Neurosci Bull. 2008 Jun;24(3):133-42. doi: 10.1007/s12264-008-1225-9. Neurosci Bull. 2008. PMID: 18500385 Free PMC article.
-
Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson's disease: mitochondrial DNA integrity.Arch Med Sci. 2017 Apr 1;13(3):659-669. doi: 10.5114/aoms.2017.67284. Epub 2017 Apr 20. Arch Med Sci. 2017. PMID: 28507584 Free PMC article.
-
Pentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease.Parkinsons Dis. 2015;2015:108179. doi: 10.1155/2015/108179. Epub 2015 Sep 29. Parkinsons Dis. 2015. PMID: 26491600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
